Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Child's Nervous System
Erschienen in: Child's Nervous System 9/2013

01.09.2013 | Special Annual Issue

Myelomeningocele: the management of the associated hydrocephalus

verfasst von: G. Tamburrini, P. Frassanito, K. Iakovaki, F. Pignotti, C. Rendeli, D. Murolo, C. Di Rocco

Erschienen in: Child's Nervous System | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

The pathogenesis of the hydrocephalus associated with myelomeningocele (MMC) has been the subject of an extensive number of studies. The contemporary reduction of the incidence of the Chiari II malformation and of the associated active hydrocephalus after closure of the spinal defect in utero is in line with previous studies suggesting a prominent role of the posterior cranial fossa abnormalities, where even the increased venous pressure might be at least mostly a consequence of the constriction of the posterior cranial fossa structures. Pure absorptive abnormalities however coexist, the main ones documented to be abnormal cisternal spaces and peculiar cerebrospinal fluid chemical features.

Materials and methods

We reviewed the pertinent literature concerning the pathogenesis and management of the hydrocephalus associated to MMC. We also reviewed our personal experience in managing the hydrocephalus in such patients through an endoscopic third ventriculostomy.

Results and conclusions

The literature review demonstrated an overall reduction in more recent series of children with MMC needing to be treated for the associated hydrocephalus postnatally, questioning the role of the prenatal care of the disease in this context. Less severe conditions and a more conservative neurosurgical attitude have certainly contributed to the reduction of the reported active postnatal hydrocephalus rate. Long-term cognitive evaluation of the children with MMC that we managed with an endoscopic third ventriculocisternostomy (ETV) as primary as well as secondary procedure did not demonstrate significant differences in the outcome compared with non-complicated extrathecally shunted children, favouring ETV as a valuable option in this subset of patients.
Literatur
1.
Arslan M, Eseoglu M, Gudu BO, Demir I, Kozan A, Gokalp A, Sosuncu E, Kiymaz N (2011) Comparison of simultaneous shunting to delayed shunting in infants with myelomeningocele in terms of shunt infection rate. Turk Neurosurg 21(3):397–402PubMed
2.
Beems T, Grotenhuis JA (2002) Is the success rate of endoscopic third ventriculostomy age dependent? An analysis of the results of third ventriculostomy in young children. Childs Nerv Syst 18:605–608PubMedCrossRef
3.
Bell WO, Arbit E, Fraser RA (1987) One-stage meningomyelocele closure and ventriculoperitoneal shunt placement. Surg Neurol 27(3):233–236PubMedCrossRef
4.
Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA (2001) Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg 34(3):114–120PubMedCrossRef
5.
Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, Hernanz-Schulman M, Lowe LH, Reed GW (1999) Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 282(19):1819–1825PubMedCrossRef
6.
Bruner JP, Tulipan N, Reed G, Davis GH, Bennett K, Luker KS, Dabrowiak ME (2004) Intrauterine repair of spina bifida: preoperative predictors of shunt-dependent hydrocephalus. Am J Obstet Gynecol 190(5):1305–1312PubMedCrossRef
7.
Caldarelli M, Di Rocco C, La Marca F (1996) Shunt complications in the first postoperative year in children with meningomyelocele. Childs Nerv Syst 12(12):748–754PubMedCrossRef
8.
Castellino RA, Zatz LM, DeNardo GL (1969) Radioisotope ventriculography in the Arnold-Chiari malformation. Radiology 93(4):817–821PubMed
9.
Chadduck WM, Reding DL (1988) Experience with simultaneous ventriculo-peritoneal shunt placement and myelomeningocele repair. J Pediatr Surg 23(10):913–916PubMedCrossRef
10.
Chakraborty A, Crimmins D, Hayward R, Thompson D (2008) Toward reducing shunt placement rates in patients with myelomeningocele. J Neurosurg Pediatr 1:361–365PubMedCrossRef
11.
Cinalli G (2004) Endoscopic third ventriculostomy. In: Cinalli G, Maixner WJ, Sainte-Rose C (eds) Pediatric hydrocephalus. Springer, Milan, pp 361–388
12.
Clemmensen D, Rasmussen MM, Mosdal C (2010) A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics. Childs Nerv Syst 26:1517–1521PubMedCrossRef
13.
Di Rocco C, Cinalli G, Massimi L, Spennato P, Cianciulli E, Tamburrini G (2006) Endoscopic third ventriculostomy in the treatment of hydrocephalus in pediatric patients. Adv Tech Stand Neurosurg 31:119–219PubMedCrossRef
14.
Di Rocco C, Rende M (1987) Neural tube defects. Some remarks on the possible role of glycosaminoglycans in the genesis of the dysraphic state, the anomaly in the configuration of the posterior cranial fossa, and hydrocephalus. Childs Nerv Syst 3(6):334–341PubMedCrossRef
15.
Dirks PB, Drake JM, Lamberti-Pasculli M, Rutka JT, Humphreys RP, McDonald P (2003) Falling ventriculoperitoneal shunt rates in myelomeningocele. Childs Nerv Syst 19:607
16.
Elgamal EA (2012) Natural history of hydrocephalus in children with spinal open neural tube defect. Surg Neurol Int 3:112PubMedCrossRef
17.
Epstein NE, Rosenthal AD, Zito J, Osipoff M (1985) Shunt placement and myelomeningocele repair: simultaneous vs sequential shunting. Review of 12 cases. Childs Nerv Syst 1:145–147PubMedCrossRef
18.
Fritsch MJ, Mehdorn HM (2003) Indication and controversies for endoscopic third ventriculostomy in children. Childs Nerv Syst 19(9):706–707
19.
Fukuhara T, Vorster SJ, Luciano MG (2000) Risk factors for failure of endoscopic third ventriculostomy for obstructive hydrocephalus. Neurosurgery 46:1100–1111PubMedCrossRef
20.
Genitori L, Peretta P, Mussa F, Giordano F (2004) Endoscopic third ventriculostomy in children: are age and etiology of hydrocephalus predictive factors influencing the outcome in primary and secondary treated patients? A series of 328 patients and 353 procedures. II CURAC Congress, Munich, October 8th
21.
Hubballah MY, Hoffman HJ (1987) Early repair of myelomeningocele and simultaneous insertion of ventriculoperitoneal shunt: technique and results. Neurosurgery 20(1):21–23PubMedCrossRef
22.
Hunt GM, Oakeshott P, Kerry S (1999) Link between the CSF shunt and achievement in adults with spina bifida. J Neurol Neurosurg Psychiatry 67(5):591–595PubMedCrossRef
23.
Iskandar BJ, Tubbs S, Mapstone TB, Grabb PA, Bartolucci AA, Oakes WJ (1998) Death in shunted hydrocephalic children in the 1990s. Pediatr Neurosurg 28:173–176PubMedCrossRef
24.
Jenkinson MD, Hayhurst C, Al-Jumaily M, Kandasamy J, Clark S, Mallucci CL (2009) The role of endoscopic third ventriculostomy in adult patients with hydrocephalus. J Neurosurg 110(5):861–866PubMedCrossRef
25.
Jones RF, Kwok BC, Stening WA, Vonau M (1996) Third ventriculostomy for hydrocephalus associated with spinal dysraphism: indications and contraindications. Eur J Pediatr Surg 6(Suppl 1):5–6PubMedCrossRef
26.
Kadri H, Mawla AA (2004) Variations of endoscopic ventricular anatomy in children suffering from hydrocephalus associated with myelomeningocele. Minim Invasive Neurosurg 47(6):339–341PubMedCrossRef
27.
Kestle JR, Walker ML, Investigators S (2005) A multicenter prospective cohort study of the strata valve for the management of hydrocephalus in pediatric patients. J Neurosurg 102(2 Suppl):141–145PubMed
28.
Koch D, Wagner W (2004) Endoscopic third ventriculostomy in infants of less than 1 year of age: which factors influence the outcome? Childs Nerv Syst 20:405–411PubMedCrossRef
29.
Kwick SJ, Mandera M, Bazowski P, Luszawski J, Duda I, Wolwender A, Zymon-Zagòrska A, Grzybowska K (2003) Endoscopic third ventriculostomy for hydrocephalus: early and late efficacy in relation to etiology. Acta Neurochir 145:181–184CrossRef
30.
Machado HR, de Oliveira RS (2004) Simultaneous repair of myelomeningocele and shunt insertion. Childs Nerv Syst 20:107–109PubMedCrossRef
31.
Massimi L, Paternoster G, Fasano T, Di Rocco C (2009) On the changing epidemiology of hydrocephalus. Childs Nerv Syst 25(7):795–800PubMedCrossRef
32.
McLone D, Knepper PA (1989) The cause of Chiari II malformation: a unified theory. Pediatr Neurosc 15:1–12CrossRef
33.
McLone DG, Czyzewski D, Raimondi AJ, Sommers RC (1982) Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocele. Pediatrics 70:338–342
34.
McLone DG, Dias MS (2003) The Chiari II malformation: cause and impact. Childs Nerv Syst 19(7–8):540–550PubMedCrossRef
35.
Miller PD, Pollack IF, Pang D, Albright AL (1996) Comparison of simultaneous versus delayed ventriculoperitoneal shunt insertion in children undergoing myelomeningocele repair. J Child Neurol 11(5):370–372PubMedCrossRef
36.
Mirzai H, Erşahin Y, Mutluer S, Kayahan A (1998) Outcome of patients with meningomyelocele: the Ege University experience. Childs Nerv Syst 14(3):120–123PubMedCrossRef
37.
Mori H, Oi S, Nonaka Y, Tamogami R, Muroi A (2008) Ventricular anatomy of hydrocephalus associated with myeloschisis and endoscopic third ventriculostomy. Childs Nerv Syst 24(6):717–722PubMedCrossRef
38.
Murshid WR (2000) Endoscopic third ventriculostomy: towards more indications for the treatment of non-communicating hydrocephalus. Minim Invas Neurosurg 43:75–82CrossRef
39.
Nejat F, Tajik P, El Khashab M, Kazmi SS, Khotaei GT, Salahesh S (2008) A randomized trial of ceftriaxone versus trimethoprim-sulfamethoxazole to prevent ventriculoperitoneal shunt infection. J Microbiol Immunol Infect 41(2):112–117PubMed
40.
O’Hayon BB, Drake JM, Ossip MG, Tuli S, Clarke M (1998) Frontal and occipital horn ratio: a linear estimate of ventricular size for multiple imaging modalities in pediatric hydrocephalus. Pediatr Neurosurg 29(5):245–249PubMedCrossRef
41.
Oi S, Di Rocco C (2006) Proposal of “evolution theory in cerebrospinal fluid dynamics” and minor pathway hydrocephalus in developing immature brain. Childs Nerv Syst 22(7):662–669PubMedCrossRef
42.
Oktem IS, Menkü A, Ozdemir A (2008) When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus? Turk Neurosurg 18(4):387–391PubMed
43.
Pang D (1995) Surgical complications of open spinal dysraphism. Neurosurg Clin N Am 6(2):243–257PubMed
44.
Parent AD, McMillan T (1995) Contemporaneous shunting with repair of myelomeningocele. Pediatr Neurosurg 22(3):132–136PubMedCrossRef
45.
Pavez A, Salazar C, Rivera R, Contreras J, Orellana A, Guzman C, Iribarren O, Hernandez H, Elzo J, Moraga D (2006) Description of endoscopic ventricular anatomy in myelomeningocele. Minim Invasive Neurosurg 49(3):161–167PubMedCrossRef
46.
Peretta P, Ragazzi P, Galarza M, Genitori L, Giordano F, Mussa F, Cinalli G (2006) Complications and pitfalls of neuroendoscopic surgery in children. J Neurosurg 105(3 Suppl):187–93PubMed
47.
Portillo S, Zuccaro G, Fernandez-Molina A, Houssay A, Sosa F, Konsol O, Jaimovich R, Olivella E, Ledesma J, Guevara M, Ajler G, Picco P (2004) Endoscopic third ventriculostomy in the treatment of pediatric hydrocephalus. A multicentric study. Child’s Nerv Syst 20(8–9):666–667
48.
Radmanesh F, Nejat F, El Kashab M, Ghodsi SM, Ardebili HE (2009) Shunt complications in children with myelomeningocele: effect of timing of shunt placement. J Neurosurg Pediatr 3:516–520PubMedCrossRef
49.
Rintoul NE, Sutton LN, Hubbard AM, Cohen B, Melchionni J, Pasquariello PS, Adzick NS (2002) A new look at myelomeningoceles: functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 109(3):409–413PubMedCrossRef
50.
Russell DS (1966) Observation on the pathology of hydrocephalus. Her Majesty’s Stationary Office, London, pp 21–37
51.
Sgouros S (2004) Hydrocephalus with myelomeningocele. In: Cinalli G, Meixner W, Sainte-Rose C (eds) Pediatric hydrocephalus. Springer-Verlag, Milan, pp 133–144
52.
Stein SC, Schut L (1979) Hydrocephalus in myelomeningocele. Childs Brain 5(4):413–419PubMed
53.
Steinbok P, Irvine B, Cochrane DD, Irwin BJ (1992) Long-term outcome and complications of children born with meningomyelocele. Childs Nerv Syst 8(2):92–96PubMedCrossRef
54.
Stevenson KL (2004) Chiari type II malformation: past, present, and future. Neurosurg Focus 16(2):E5PubMedCrossRef
55.
Sutton LN, Adzick NS, Bilaniuk LT, Johnson MP, Crombleholme TM, Flake AW (1999) Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA 282(19):1826–1831PubMedCrossRef
56.
Tamburrini G, Caldarelli M, Massimi L, Ramirez-Reyes G, Di Rocco C (2004) Primary and secondary third ventriculostomy in children with hydrocephalus and myelomeningocele. Child’s Nerv Syst 20(8–9):666
57.
Teo C, Jones R (1996) Management of hydrocephalus by endoscopic third ventriculostomy in patients with myelomeningocele. Pediatr Neurosurg 25:57–63PubMedCrossRef
58.
Tortori-Donati P, Rossi A, Cama A (2000) Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology 42(7):471–491PubMedCrossRef
59.
Tubbs RS, Oakes WJ (2004) Treatment and management of the Chiari II malformation: an evidence-based review of the literature. Childs Nerv Syst 20(6):375–381PubMedCrossRef
60.
Tuli S, Drake J, Lamberti-Pasculli M (2003) Long-term outcome of hydrocephalus management in myelomeningoceles. Childs Nerv Syst 19(5–6):286–291PubMedCrossRef
61.
Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M (2000) Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 92(1):31–38PubMedCrossRef
62.
Tulipan N, Hernanz-Schulman M, Lowe LH, Bruner JP (1999) Intrauterine myelomeningocele repair reverses preexisting hindbrain herniation. Pediatr Neurosurg 31(3):137–142PubMedCrossRef
63.
Tulipan N, Sutton LN, Bruner JP, Cohen BM, Johnson M, Adzick NS (2003) The effect of intrauterine myelomeningocele repair on the incidence of shunt-dependent hydrocephalus. Pediatr Neurosurg 38(1):27–33PubMedCrossRef
64.
Wakhlu A, Ansari NA (2004) The prediction of postoperative hydrocephalus in patients with spina bifida. Childs Nerv Syst 20(2):104–106PubMedCrossRef
65.
Walker DG, Coyne TJ, Kahler RJm Tomlinson FH (2003) Failure of endoscopic third ventriculostomy in myelomeningocele patients: preoperative clinical and radiological features. Child’s Nerv Syst 19(9):707–708
66.
Warf B, Ondoma S, Kulkarni A, Donnelly R, Ampeire M, Akona J, Kabachelor CR, Mulondo R, Nsubuga BK (2009) Neurocognitive outcome and ventricular volume in children with myelomeningocele treated for hydrocephalus in Uganda. J Neurosurg Pediatr 4(6):564–570PubMedCrossRef
67.
Warf BC (2011) Hydrocephalus associated with neural tube defects: characteristics, management, and outcome in sub-Saharan Africa. Childs Nerv Syst 27:1589–1594PubMedCrossRef
68.
Warf BC, Campbell JW (2008) Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants. J Neurosurg Pediatr 2(5):310–316PubMedCrossRef
69.
Williams H (2008) A unifying hypothesis for hydrocephalus, Chiari malformation, syringomyelia, anencephaly and spina bifida. Cerebrospinal Fluid Res 5:7PubMedCrossRef
Metadaten
Titel
Myelomeningocele: the management of the associated hydrocephalus
verfasst von
G. Tamburrini
P. Frassanito
K. Iakovaki
F. Pignotti
C. Rendeli
D. Murolo
C. Di Rocco
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 9/2013
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-013-2179-4

Weitere Artikel der Ausgabe 9/2013

Child's Nervous System 9/2013 Zur Ausgabe

Special Annual Issue

Urodynamic studies in spinal cord tethering

Special Annual Issue

Syringomyelia and tethered cord in children

Special Annual Issue

Limited dorsal myeloschisis: a not-so-rare form of primary neurulation defect

Special Annual Issue

Experimental models of spinal open neural tube defect and Chiari type II malformation

Special Annual Issue

Prenatal diagnosis of spinal dysraphism

Original Paper

Pathoembryogenesis of terminal myelocystocele: terminal balloon in secondary neurulation of the chick embryo

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise